---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-072151"
form_type: "8-K"
ticker: "OCUL"
cik: "0001393434"
company_name: "OCULAR THERAPEUTIX, INC"
filed_at: "2022-06-17T23:59:59+00:00"
generated_at: "2026-06-25T00:47:33.231014+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Ocular Therapeutix shareholders approve 3.6M share increase under 2021 Stock Incentive Plan

## Summary
- Stockholders approved amendment to 2021 Stock Incentive Plan, increasing authorized shares by 3,600,000.
- Elected Seung Suh Hong, Richard L. Lindstrom, and Leslie J. Williams as Class II directors until 2025.
- Non-binding advisory vote on executive compensation passed: 31,197,580 for, 10,723,248 against.
- Ratified PricewaterhouseCoopers as independent auditor for fiscal 2022 with 60,017,922 votes for.

## SEC filing metadata
- accession: 0001104659-22-072151
- form_type: 8-K
- ticker: OCUL
- cik: 0001393434
- company_name: OCULAR THERAPEUTIX, INC
- filed_at: 2022-06-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1393434/000110465922072151/0001104659-22-072151-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1393434/000110465922072151/tm2218753d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-072151
- JSON: https://secwatch.observer/filing/0001104659-22-072151.json
- Plain text: https://secwatch.observer/filing/0001104659-22-072151.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.